Susanne Wegener
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Susanne Wegener has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
Marcel Arnold
Department of Neurology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland
22 shared publicationsPatrik Michel
Stroke Center , Neurology Service, Lausanne University Hospital and University of Lausanne, Lausanne
19 shared publications- Christian H. Nolte
Department of Neurology with Experimental Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
18 shared publications - Urs Fischer
Department of Neurology, University Hospital Bern and University of Bern, Switzerland (U.F.).
18 shared publications - Carlo Walter Cereda
Stroke Center EOC, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, Lugano (C.W.C.).
17 shared publications - Andreas Rüdiger Luft
University Hospital Zurich and University of Zurich
16 shared publications
Latest Publications
- Open Access
Age and body-mass index account for part of the sex differences in cerebral venous thrombosis
Background: Women with cerebral venous thrombosis are younger than men and more often present with headache, but these differences have not been adjusted for age or body-mass index, both of which differ by sex. Methods: Single-center cohort of 219 consecutive adults with confirmed cerebral venous thrombosis admitted in Zurich in 2001-2021. Presentation, imaging and laboratory findings were compared between women and men, and every difference was re-estimated at equal age and body-mass index. Secondary analyses compared functional outcome, residual symptoms and return to work by sex, with an audit of incomplete follow-up. Results: Women (132, 60.3%) were younger (47.3 versus 54.9 years) and had a lower body-mass index (25.9 versus 27.8 kg/m²) than men. Headache (72.0% versus 57.5%) and cortical vein thrombosis (14.4% versus 5.7%) were more frequent in women, but neither association persisted after adjustment (odds ratios, 1.17 [95% CI, 0.54-2.54] and 2.05 [95% CI, 0.59-7.06]). Higher platelet counts (+56 × 10⁹/L [95% CI, 26-86]) and elevated acute-phase markers without documented infection (59.1% versus 33.3%; odds ratio, 2.91 [95% CI, 1.44-5.87]) persisted after adjustment for age, body-mass index and calendar period. Among assessed patients (38% at 6 months), functional independence (86.3% versus 87.5%), residual headache, return to work and recanalization did not differ by sex. Conclusions: At equal age and body-mass index, the female excess of headache and cortical vein involvement was no longer apparent, whereas a higher platelet count and a non-specific acute-phase response remained. Neither translated into a difference in outcome among assessed patients. Clinical Perspective: What Is New?: In 219 consecutive adults with cerebral venous thrombosis, the female excess of headache and cortical vein thrombosis reported by the large registries was attenuated once age and body-mass index were accounted for, whereas higher platelet counts and more frequent elevation of acute-phase markers without infection in women persisted. Women without a sex-specific risk factor resembled men in age and in the frequency of headache, which suggests that part of the female phenotype of cerebral venous thrombosis is a phenotype of young age and reproductive exposures. What Are the Clinical Implications?: Sex differences in presentation were not accompanied by differences in functional outcome, residual symptoms, return to work, or recanalization among the patients assessed, so sex alone does not identify patients who need a different follow-up.
Open AccessAge and body-mass index account for part of the sex differences in cerebral venous thrombosis
Background: Women with cerebral venous thrombosis are younger than men and more often present with headache, but these differences have not been adjusted for age or body-mass index, both of which differ by sex. Methods: Single-center cohort of 219 consecutive adults with confirmed cerebral venous thrombosis admitted in Zurich in 2001-2021. Presentation, imaging and laboratory findings were compared between women and men, and every difference was re-estimated at equal age and body-mass index. Secondary analyses compared functional outcome, residual symptoms and return to work by sex, with an audit of incomplete follow-up. Results: Women (132, 60.3%) were younger (47.3 versus 54.9 years) and had a lower body-mass index (25.9 versus 27.8 kg/m²) than men. Headache (72.0% versus 57.5%) and cortical vein thrombosis (14.4% versus 5.7%) were more frequent in women, but neither association persisted after adjustment (odds ratios, 1.17 [95% CI, 0.54-2.54] and 2.05 [95% CI, 0.59-7.06]). Higher platelet counts (+56 × 10⁹/L [95% CI, 26-86]) and elevated acute-phase markers without documented infection (59.1% versus 33.3%; odds ratio, 2.91 [95% CI, 1.44-5.87]) persisted after adjustment for age, body-mass index and calendar period. Among assessed patients (38% at 6 months), functional independence (86.3% versus 87.5%), residual headache, return to work and recanalization did not differ by sex. Conclusions: At equal age and body-mass index, the female excess of headache and cortical vein involvement was no longer apparent, whereas a higher platelet count and a non-specific acute-phase response remained. Neither translated into a difference in outcome among assessed patients. Clinical Perspective: What Is New?: In 219 consecutive adults with cerebral venous thrombosis, the female excess of headache and cortical vein thrombosis reported by the large registries was attenuated once age and body-mass index were accounted for, whereas higher platelet counts and more frequent elevation of acute-phase markers without infection in women persisted. Women without a sex-specific risk factor resembled men in age and in the frequency of headache, which suggests that part of the female phenotype of cerebral venous thrombosis is a phenotype of young age and reproductive exposures. What Are the Clinical Implications?: Sex differences in presentation were not accompanied by differences in functional outcome, residual symptoms, return to work, or recanalization among the patients assessed, so sex alone does not identify patients who need a different follow-up.
- 1 November 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (11) , 3441-3450
Responsible AI for Acute Stroke Management
Artificial intelligence is increasingly integrated into acute stroke management, demonstrating strong performance in tasks such as large vessel occlusion detection, Alberta Stroke Program Early Computed Tomography Score scoring, and functional outcome prediction. However, concerns persist regarding both the black-box nature of these models and algorithmic bias that may exacerbate disparities in stroke incidence, treatment, and outcomes across racial and socioeconomic subgroups. This review synthesizes the current literature on explainable artificial intelligence and fairness in artificial intelligence applications for acute stroke management, identifies persistent challenges, and outlines recommendations for the development of equitable and trustworthy systems in stroke care. Recent studies have increasingly adopted post hoc explainability methods, though these are limited by approximation and misleading interpretations, especially since explanations are rarely formally tested. Explainability and fairness remain largely disconnected, with fairness evaluation remaining uncommon due to limited demographic metadata, regulatory constraints, and the absence of stroke-specific fairness criteria. Generalizability also remains a concern due to suboptimal data set partitioning strategies and inadequate reporting practices. Responsible artificial intelligence for acute stroke management requires unified evaluation frameworks that jointly assess explainability, fairness, and generalizability.
- 1 November 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (11) , 3441-3450
Responsible AI for Acute Stroke Management
Artificial intelligence is increasingly integrated into acute stroke management, demonstrating strong performance in tasks such as large vessel occlusion detection, Alberta Stroke Program Early Computed Tomography Score scoring, and functional outcome prediction. However, concerns persist regarding both the black-box nature of these models and algorithmic bias that may exacerbate disparities in stroke incidence, treatment, and outcomes across racial and socioeconomic subgroups. This review synthesizes the current literature on explainable artificial intelligence and fairness in artificial intelligence applications for acute stroke management, identifies persistent challenges, and outlines recommendations for the development of equitable and trustworthy systems in stroke care. Recent studies have increasingly adopted post hoc explainability methods, though these are limited by approximation and misleading interpretations, especially since explanations are rarely formally tested. Explainability and fairness remain largely disconnected, with fairness evaluation remaining uncommon due to limited demographic metadata, regulatory constraints, and the absence of stroke-specific fairness criteria. Generalizability also remains a concern due to suboptimal data set partitioning strategies and inadequate reporting practices. Responsible artificial intelligence for acute stroke management requires unified evaluation frameworks that jointly assess explainability, fairness, and generalizability.
- Open Access
- 21 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (10) , 1136
Intraoperative Measurement of Internal Carotid Artery Blood Flow Using Transit-Time Flowmetry After Carotid Endarterectomy: Results from 196 Consecutive Cases
Background/Objectives: Carotid endarterectomy (CEA) is a standard surgical treatment for high-grade symptomatic and asymptomatic internal carotid artery (ICA) stenosis. The Transit Time Flowmeter (TTF) provides an easy-to-use tool to quantify intraoperative ICA blood flow in mL/min. This study aimed to (1) describe post-CEA ICA flow quantified with TTF, (2) identify predictors of post-CEA ICA flow, and (3) examine its association with contralateral steno-occlusive disease. Methods: We queried data from our prospective registry of patients who underwent a CEA between January 2019 and July 2024 and had intraoperative registered post-CEA ICA flow measurements using TTF. Preoperative ICA stenosis was graded according to the NASCET criteria. The clinical data was retrospectively collected. Results: Data from 196 CEAs in 190 patients (median age 74 [67–81]; 25% female) were included. Most patients (86%) had a symptomatic ICA stenosis. The median post-CEA ICA flow was 170 mL/min [IQR 140–242; range 40–800]. Post-CEA ICA flow was not associated with age, sex, comorbidities, symptomatic stenosis, left ventricular ejection fraction (LVEF), or ipsilateral stenosis severity but was significantly higher in patients requiring intraluminal shunt placement during CEA (p = 0.010) as well as in those with contralateral steno-occlusive disease (p < 0.001). Conclusions: TTF is a practical intraoperative tool for quantitative flow assessment during CEA. Higher post-CEA ICA flow in patients with an intraoperative shunt placement or with contralateral steno-occlusive disease may reflect a compensatory hyperperfusion, as the ipsilateral ICA serves as a key supplier when collateral pathways are incomplete.
- 21 October 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (10) , 1136
Open AccessIntraoperative Measurement of Internal Carotid Artery Blood Flow Using Transit-Time Flowmetry After Carotid Endarterectomy: Results from 196 Consecutive Cases
Background/Objectives: Carotid endarterectomy (CEA) is a standard surgical treatment for high-grade symptomatic and asymptomatic internal carotid artery (ICA) stenosis. The Transit Time Flowmeter (TTF) provides an easy-to-use tool to quantify intraoperative ICA blood flow in mL/min. This study aimed to (1) describe post-CEA ICA flow quantified with TTF, (2) identify predictors of post-CEA ICA flow, and (3) examine its association with contralateral steno-occlusive disease. Methods: We queried data from our prospective registry of patients who underwent a CEA between January 2019 and July 2024 and had intraoperative registered post-CEA ICA flow measurements using TTF. Preoperative ICA stenosis was graded according to the NASCET criteria. The clinical data was retrospectively collected. Results: Data from 196 CEAs in 190 patients (median age 74 [67–81]; 25% female) were included. Most patients (86%) had a symptomatic ICA stenosis. The median post-CEA ICA flow was 170 mL/min [IQR 140–242; range 40–800]. Post-CEA ICA flow was not associated with age, sex, comorbidities, symptomatic stenosis, left ventricular ejection fraction (LVEF), or ipsilateral stenosis severity but was significantly higher in patients requiring intraluminal shunt placement during CEA (p = 0.010) as well as in those with contralateral steno-occlusive disease (p < 0.001). Conclusions: TTF is a practical intraoperative tool for quantitative flow assessment during CEA. Higher post-CEA ICA flow in patients with an intraoperative shunt placement or with contralateral steno-occlusive disease may reflect a compensatory hyperperfusion, as the ipsilateral ICA serves as a key supplier when collateral pathways are incomplete.
- Open Access
- 15 October 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (11) , 662
Retinal layer thickness as a potential marker for future cardiovascular events - a UK Biobank cohort study using optical coherence tomography
Aims: Cardiovascular disease (CVD) is the leading cause of death worldwide. For CVD prevention, effective screening is needed to identify high-risk individuals. Optical coherence tomography (OCT) provides a noninvasive, low-cost “quick look” into the brain and has recently shown thinning of certain retinal layers in patients with previous CVD. We explored if OCT-derived retinal layer thicknesses could predict future major adverse cardiovascular events (MACE: stroke/myocardial infarction/cardiovascular death). Methods: In this retrospective cohort study, data of 51,293 participants from the UK Biobank were analyzed. We used cause-specific hazard models to evaluate the association of retinal nerve fiber layer thickness (RNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness with incident MACE, adjusting models for cardiovascular risk factors (CVRF) and performed subanalyses for association with incident stroke and myocardial infarction. Results: Median follow-up time was 14.7 years. Both RNFL thickness (aHR 0.92, 95% CI 0.89–0.96, p < 0.001) and GCIPL thickness (aHR 0.96, 95% CI 0.92–1.00, p = 0.04) were statistically associated with incident MACE in cause-specific hazard models adjusted for CVRF. Interestingly, RNFL thickness was more strongly associated with incident myocardial infarction (aHR 0.94, 95% CI 0.88–0.99, p = 0.02) while GCIPL was more strongly associated with incident stroke (aHR 0.90, 95% CI 0.83–0.96, p = 0.003). Conclusion: RNFL and GCIPL thicknesses are associated with future MACE, even after adjusting for CVRF. OCT-measured retinal layer thickness could contribute to the assessment of cardiovascular risk. Graphical Key question : Can measurement of retinal layer thickness by optical coherence tomography (OCT) improve prediction of incident cardiovascular events? Key finding : Retinal nerve fiber layer (RNFL) thickness and ganglion cell-inner plexiform layer (GCIPL) thickness are associated with incident major adverse cardiovascular events (MACE). They lead to modest improvements in prediction of MACE when both layers were added to a cause-specific hazard model based on age and sex. Take-home message : Measures of retinal layer thickness using OCT have the potential to improve cardiovascular risk screening.
- 15 October 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (11) , 662
Open AccessRetinal layer thickness as a potential marker for future cardiovascular events - a UK Biobank cohort study using optical coherence tomography
Aims: Cardiovascular disease (CVD) is the leading cause of death worldwide. For CVD prevention, effective screening is needed to identify high-risk individuals. Optical coherence tomography (OCT) provides a noninvasive, low-cost “quick look” into the brain and has recently shown thinning of certain retinal layers in patients with previous CVD. We explored if OCT-derived retinal layer thicknesses could predict future major adverse cardiovascular events (MACE: stroke/myocardial infarction/cardiovascular death). Methods: In this retrospective cohort study, data of 51,293 participants from the UK Biobank were analyzed. We used cause-specific hazard models to evaluate the association of retinal nerve fiber layer thickness (RNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness with incident MACE, adjusting models for cardiovascular risk factors (CVRF) and performed subanalyses for association with incident stroke and myocardial infarction. Results: Median follow-up time was 14.7 years. Both RNFL thickness (aHR 0.92, 95% CI 0.89–0.96, p < 0.001) and GCIPL thickness (aHR 0.96, 95% CI 0.92–1.00, p = 0.04) were statistically associated with incident MACE in cause-specific hazard models adjusted for CVRF. Interestingly, RNFL thickness was more strongly associated with incident myocardial infarction (aHR 0.94, 95% CI 0.88–0.99, p = 0.02) while GCIPL was more strongly associated with incident stroke (aHR 0.90, 95% CI 0.83–0.96, p = 0.003). Conclusion: RNFL and GCIPL thicknesses are associated with future MACE, even after adjusting for CVRF. OCT-measured retinal layer thickness could contribute to the assessment of cardiovascular risk. Graphical Key question : Can measurement of retinal layer thickness by optical coherence tomography (OCT) improve prediction of incident cardiovascular events? Key finding : Retinal nerve fiber layer (RNFL) thickness and ganglion cell-inner plexiform layer (GCIPL) thickness are associated with incident major adverse cardiovascular events (MACE). They lead to modest improvements in prediction of MACE when both layers were added to a cause-specific hazard model based on age and sex. Take-home message : Measures of retinal layer thickness using OCT have the potential to improve cardiovascular risk screening.
- Open Access
- 13 October 2026
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
Functional outcome after ischaemic stroke and intracerebral haemorrhage from two national cohorts
- 13 October 2026
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
Open AccessFunctional outcome after ischaemic stroke and intracerebral haemorrhage from two national cohorts
- Open Access
- 29 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (40)
Loss of cerebral autoregulation drives abnormal perfusion patterns after stroke
Maintaining a stable cerebral blood flow (CBF) despite variations in blood pressure is crucial for normal brain function. This process, called cerebral autoregulation, is often impaired in pathologies such as ischemic stroke, underlining its clinical importance. However, how local vascular responses interact across complex cerebrovascular networks to stabilize perfusion remains poorly understood. Here, we present an in silico model of static autoregulation that can be applied to realistic microvascular networks, providing vessel-specific insights into vasoreactivity and perfusion dynamics. Our simulations revealed a hierarchical organization of autoregulatory responses, in which pial surface arteries act as key regulators that buffer pressure changes across large vascular territories. Arterial density emerged as a decisive determinant of network-specific autoregulatory capacity, highlighting the importance of vascular topology for maintaining stable perfusion. During poststroke reperfusion, alterations in vasoreactivity, rather than collateral extent alone, emerged as the main contributor to pathogenic hyperperfusion. Simulations of chronic autoregulatory dysfunction showed that progressive loss of vascular reactivity can produce substantial downstream disturbances in capillary perfusion and alter the autoregulation curve. Overall, our framework reveals how interactions between vascular topology and vessel-specific regulatory mechanisms shape CBF regulation across scales, from individual arteries to whole-network perfusion. These findings highlight myogenic tone as a potential therapeutic target to reduce reperfusion-related complications in stroke.
- 29 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (40)
Open AccessLoss of cerebral autoregulation drives abnormal perfusion patterns after stroke
Maintaining a stable cerebral blood flow (CBF) despite variations in blood pressure is crucial for normal brain function. This process, called cerebral autoregulation, is often impaired in pathologies such as ischemic stroke, underlining its clinical importance. However, how local vascular responses interact across complex cerebrovascular networks to stabilize perfusion remains poorly understood. Here, we present an in silico model of static autoregulation that can be applied to realistic microvascular networks, providing vessel-specific insights into vasoreactivity and perfusion dynamics. Our simulations revealed a hierarchical organization of autoregulatory responses, in which pial surface arteries act as key regulators that buffer pressure changes across large vascular territories. Arterial density emerged as a decisive determinant of network-specific autoregulatory capacity, highlighting the importance of vascular topology for maintaining stable perfusion. During poststroke reperfusion, alterations in vasoreactivity, rather than collateral extent alone, emerged as the main contributor to pathogenic hyperperfusion. Simulations of chronic autoregulatory dysfunction showed that progressive loss of vascular reactivity can produce substantial downstream disturbances in capillary perfusion and alter the autoregulation curve. Overall, our framework reveals how interactions between vascular topology and vessel-specific regulatory mechanisms shape CBF regulation across scales, from individual arteries to whole-network perfusion. These findings highlight myogenic tone as a potential therapeutic target to reduce reperfusion-related complications in stroke.
- Open Access
- 15 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (18)
Sex Differences in Cardiac Rhythm and Conduction Abnormalities After Noncardioembolic Ischemic Stroke
Background: Cardiac pathologies can occur after acute ischemic stroke (AIS) even in patients without prior heart disease, reflecting bidirectional brain–heart interactions. We investigated sex‐specific differences in newly diagnosed cardiac pathologies within 1 year after noncardioembolic AIS. Methods: We screened 7113 patients with a first cerebrovascular event (December 2013 to March 2021) at a tertiary stroke center and included 673 patients (39% women, aged 61.2 years) with noncardioembolic AIS and no evidence of previous cardiac disease. After AIS, all patients received standard cardiologic evaluation (24‐hour in‐hospital telemetry, 24‐hour blood pressure monitoring, echocardiography, and 48‐hour Holter ECG). Electronic health records were reviewed for cardiology consultations and testing within 1 year after the index event (eg, ECG, echocardiography, coronary computed tomographic angiography, cardiac magnetic resonance imaging, myocardial perfusion single‐photon emission computed tomography). Multivariable binary logistic regression models were adjusted for age, antihypertensive and lipid‐lowering therapy, hypertension, diabetes, hyperlipidemia, and smoking. Results: Compared with women, men more frequently exhibited nonsustained ventricular tachycardia (odds ratio, 3.97 [95% CI, 1.14–13.86]; P =0.031), first‐degree atrioventricular block (odds ratio, 5.71 [95% CI, 1.48–22.01]; P =0.013), bradycardia (odds ratio, 3.40 [95% CI, 1.50–7.67]; P =0.003), and polymorphic ventricular extrasystoles (odds ratio, 2.61 [95% CI, 1.43–4.74]; P =0.002) within 1 year after AIS. Findings were consistent after multivariable adjustment. Conclusions: In this single‐center cohort of patients without known heart disease and noncardioembolic AIS, poststroke cardiac findings were more common in men, particularly nonsustained ventricular tachycardia and polymorphic ventricular extrasystoles. These hypothesis‐generating observations support further investigation into sex‐informed poststroke cardiac evaluation.
- 15 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (18)
Open AccessSex Differences in Cardiac Rhythm and Conduction Abnormalities After Noncardioembolic Ischemic Stroke
Background: Cardiac pathologies can occur after acute ischemic stroke (AIS) even in patients without prior heart disease, reflecting bidirectional brain–heart interactions. We investigated sex‐specific differences in newly diagnosed cardiac pathologies within 1 year after noncardioembolic AIS. Methods: We screened 7113 patients with a first cerebrovascular event (December 2013 to March 2021) at a tertiary stroke center and included 673 patients (39% women, aged 61.2 years) with noncardioembolic AIS and no evidence of previous cardiac disease. After AIS, all patients received standard cardiologic evaluation (24‐hour in‐hospital telemetry, 24‐hour blood pressure monitoring, echocardiography, and 48‐hour Holter ECG). Electronic health records were reviewed for cardiology consultations and testing within 1 year after the index event (eg, ECG, echocardiography, coronary computed tomographic angiography, cardiac magnetic resonance imaging, myocardial perfusion single‐photon emission computed tomography). Multivariable binary logistic regression models were adjusted for age, antihypertensive and lipid‐lowering therapy, hypertension, diabetes, hyperlipidemia, and smoking. Results: Compared with women, men more frequently exhibited nonsustained ventricular tachycardia (odds ratio, 3.97 [95% CI, 1.14–13.86]; P =0.031), first‐degree atrioventricular block (odds ratio, 5.71 [95% CI, 1.48–22.01]; P =0.013), bradycardia (odds ratio, 3.40 [95% CI, 1.50–7.67]; P =0.003), and polymorphic ventricular extrasystoles (odds ratio, 2.61 [95% CI, 1.43–4.74]; P =0.002) within 1 year after AIS. Findings were consistent after multivariable adjustment. Conclusions: In this single‐center cohort of patients without known heart disease and noncardioembolic AIS, poststroke cardiac findings were more common in men, particularly nonsustained ventricular tachycardia and polymorphic ventricular extrasystoles. These hypothesis‐generating observations support further investigation into sex‐informed poststroke cardiac evaluation.
- Open Access
Brain pericytes exhibit spatially organized and dynamically regulated molecular heterogeneity
Brain capillary pericytes are essential components of the neurovascular unit, yet the extent of their molecular heterogeneity within intact vascular networks remains poorly understood. Here, we combined spatial imaging with reanalysis of independent single-cell transcriptomic datasets to investigate the molecular organization of adult mouse brain pericytes. We identified spatial organization of pericyte molecular heterogeneity associated with anatomical region and position within the vascular network, including recurrent differences in ACE2, CASQ2, Igf2, and OPN expression. Moreover, pericyte molecular phenotypes varied with aging, acute ischemia, and circadian phase. Notably, light–dark phase emerged as a major axis of transcriptional variation, with pericytes exhibiting distinct circadian phase-associated molecular states. Together, these data demonstrate that adult brain pericytes exhibit spatially organized and dynamically regulated molecular heterogeneity associated with vascular and physiological context.
Open AccessBrain pericytes exhibit spatially organized and dynamically regulated molecular heterogeneity
Brain capillary pericytes are essential components of the neurovascular unit, yet the extent of their molecular heterogeneity within intact vascular networks remains poorly understood. Here, we combined spatial imaging with reanalysis of independent single-cell transcriptomic datasets to investigate the molecular organization of adult mouse brain pericytes. We identified spatial organization of pericyte molecular heterogeneity associated with anatomical region and position within the vascular network, including recurrent differences in ACE2, CASQ2, Igf2, and OPN expression. Moreover, pericyte molecular phenotypes varied with aging, acute ischemia, and circadian phase. Notably, light–dark phase emerged as a major axis of transcriptional variation, with pericytes exhibiting distinct circadian phase-associated molecular states. Together, these data demonstrate that adult brain pericytes exhibit spatially organized and dynamically regulated molecular heterogeneity associated with vascular and physiological context.
- 23 July 2026
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 3 (8)
The TopCoW Challenge — Topology-Aware Circle of Willis Segmentation for CT and MR Angiography
- 23 July 2026
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 3 (8)
The TopCoW Challenge — Topology-Aware Circle of Willis Segmentation for CT and MR Angiography
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (7) , 1871-1884
Inflammation in Acute Ischemic Stroke: Translational Barriers and Implications for Treatment
Cerebral ischemia triggers a cascade of molecular events over minutes to days, which activate immune cells, inflammation, and coagulation, promoting cell death. These processes critically influence both short- and long-term outcomes in patients with stroke. In this review, we address the role of immune molecular and cellular factors, and the therapeutic approaches predicted to be targetable by specific agents under a timely application. We will focus on translational efforts targeting (thrombo)-inflammatory mechanisms, highlighting past missteps and current opportunities. Finally, we outline key mechanistic and methodological questions that may define a path forward.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (7) , 1871-1884
Inflammation in Acute Ischemic Stroke: Translational Barriers and Implications for Treatment
Cerebral ischemia triggers a cascade of molecular events over minutes to days, which activate immune cells, inflammation, and coagulation, promoting cell death. These processes critically influence both short- and long-term outcomes in patients with stroke. In this review, we address the role of immune molecular and cellular factors, and the therapeutic approaches predicted to be targetable by specific agents under a timely application. We will focus on translational efforts targeting (thrombo)-inflammatory mechanisms, highlighting past missteps and current opportunities. Finally, we outline key mechanistic and methodological questions that may define a path forward.